Report ID: SQMIG35E2026
Report ID:
SQMIG35E2026 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
65 |
Figures:
75
North America holds 35.98% of the market in 2022, owing to several well-established pharmaceutical companies actively expanding their global reach and marketing their products. Overall, the growing number of pet owners, the development of animals medical, increasing demand for specialty services and expanding pet insurance. The potential of veterinary care is accessible and is expected to drive the growth of the market.
Asia Pacific in the market is expected to grow at the fastest CAGR during the forecast period. International companies are investing heavily in R&D and ongoing programs to commercialize low-cost veterinary drugs and vaccines. Furthermore, the urgent need to reduce common animal diseases the presence of anticipated market growth in the coming years drives the market size. One of the main reasons for affecting the health of working animals is the rise in pet adoptions. With increasing pet adoption and increasing adoption of western lifestyle, the perception of pet owners in this area is changing. This change in pet adoption is expected to drive market growth.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35E2026